发明名称 |
Anti-ETBR antibodies and immunoconjugates |
摘要 |
The invention provides anti-ETBR antibodies and immunoconjugates and methods of using the same. In some embodiments, an immunoconjugate comprising an antibody that binds ETBR covalently attached to a cytotoxic agent is provided, wherein the antibody binds an epitope within amino acids 64 to 101 of SEQ ID NO: 10. In some embodiments, the cytotoxic agent is a pyrrolobenzodiazepine. |
申请公布号 |
US9464141(B2) |
申请公布日期 |
2016.10.11 |
申请号 |
US201314418314 |
申请日期 |
2013.08.01 |
申请人 |
Genentech, Inc. |
发明人 |
Asundi Jyoti;Clark Suzanna;Polakis Paul |
分类号 |
A61K39/395;C07K16/30;C07K16/28;A61K47/48;A61K31/551;A61K45/06;A61K39/00 |
主分类号 |
A61K39/395 |
代理机构 |
McNeill Baur PLLC |
代理人 |
McNeill Baur PLLC |
主权项 |
1. A method of treating an individual having an ETBR-positive cancer, wherein the ETBR-positive cancer is resistant to a first immunoconjugate comprising a first antibody that binds ETBR and a first cytotoxic agent which is an auristatin, the method comprising administering to the individual an effective amount of an immunoconjugate comprising an antibody that binds ETBR covalently attached to a cytotoxic agent, wherein the antibody binds an epitope within amino acids 64 to 101 of SEQ ID NO: 10, and wherein the cytotoxic agent is a pyrrolobenzodiazepine. |
地址 |
South San Francisco CA US |